PT - JOURNAL ARTICLE AU - Su, Hang AU - Cheng, Yafang AU - Pöschl, Ulrich TI - Synergetic measures needed to prevent infection waves and contain SARS-CoV-2 transmission AID - 10.1101/2021.11.24.21266824 DP - 2021 Jan 01 TA - medRxiv PG - 2021.11.24.21266824 4099 - http://medrxiv.org/content/early/2021/11/27/2021.11.24.21266824.short 4100 - http://medrxiv.org/content/early/2021/11/27/2021.11.24.21266824.full AB - We investigate the effectiveness and synergies of vaccination and non-pharmaceutical interventions like masking, distancing & ventilation, testing & isolation, and contact reduction as a function of compliance in the population. For realistic conditions, we find that it would be difficult to contain highly contagious SARS-CoV-2 variants by any individual measure. Instead, we show how multiple synergetic measures have to be combined to reduce the effective reproduction number (Re) below unity. For R0=5 and ~70% vaccination rate, the synergies of masking, distancing & ventilation, and testing & isolation with compliances around 30% appear suitable to keep Re<1. With frequent testing, this would work also at lower vaccination rates, e.g., in schools. Higher compliance or additional measures like contact reductions are required to break intense waves of infection.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by the Max Planck Society.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors once the manuscript is published in peer-review journals.